Quarterly Results

  • Company Name :
Aurobindo Pharma Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 524804
  • NSE Symbol:
  • AUROPHARMA
  • P/E(TTM):
  • 33.17
  • ISIN Demat:
  • INE406A01037
  • Div & Yield%:
  • 0.38
  • EPS(TTM):
  • 35.31
  • Book Value(₹):
  • 335.50
  • Market Cap(₹Cr.):
  • 68,625.13
  • Face Value(₹):
  • 1.00
Quarters :  
Particulars September 2024 ( Cr)June 2024 ( Cr)March 2024 ( Cr)
Gross Sales 2,757.88 2,425.22 2,866.40
Excise Duty 0.00 0.00 0.00
Net Sales 2,757.88 2,425.22 2,866.40
Other Operating Income 66.71 34.87 27.63
Other Income 122.66 65.32 122.97
Total Income 2,947.25 2,525.41 3,017.00
Total Expenditure 2,103.71 1,961.16 2,119.24
PBIDT 843.54 564.25 897.76
Interest 51.63 51.13 53.07
PBDT 791.91 513.12 844.69
Depreciation 68.16 66.88 64.81
Tax 188.43 119.66 207.66
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax -2.21 -2.46 -6.45
Reported Profit After Tax 537.53 329.04 578.67
Extra-ordinary Items 0.00 0.00 0.00
Adjusted Profit After Extra-ordinary item 537.53 329.04 578.67
EPS (Unit Curr.) 9.21 5.62 9.88
EPS (Adj) (Unit Curr.) 9.21 5.62 9.88
Calculated EPS (Unit Curr.) 9.25 5.62 9.88
Calculated EPS (Adj) (Unit Curr.) 9.25 5.62 9.88
Calculated EPS (Ann.) (Unit Curr.) 37.02 22.46 39.51
Calculated EPS (Adj) (Ann.) (Unit Curr.) 37.02 22.46 39.51
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 58.08 58.59 58.59
Reserve & Surplus 19,598.16 0.00 0.00
Face Value 1.00 1.00 1.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 30.59 23.27 31.32
PBDTM(%) 28.71 21.16 29.47
PATM(%) 19.49 13.57 20.19